IWP
GSK icon

Innova Wealth Partners’s GSK GSK Stock Holding History

Innova Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Hold
6,940
– – 0.15% 120
2026
Q1 		$383K Sell
6,940
-1,011
-13% -$54.8K 0.18% 94
2025
Q4 		$390K Sell
7,951
-589
-7% -$27.5K 0.2% 76
2025
Q3 		$369K Sell
8,540
-100
-1% -$3.91K 0.2% 78
2025
Q2 		$332K Sell
8,640
-422
-5% -$16.1K 0.2% 71
2025
Q1 		$351K Hold
9,062
– – 0.22% 65
2024
Q4 		$306K Buy
+9,062
New +$326K 0.19% 70
2024
Q3 		– Sell
-10,111
Closed -$389K – 98
2024
Q2 		$389K Hold
10,111
– – 0.28% 54
2024
Q1 		$433K Sell
10,111
-663
-6% -$27.3K 0.33% 49
2023
Q4 		$399K Sell
10,774
-1,000
-8% -$35.9K 0.34% 42
2023
Q3 		$427K Hold
11,774
– – 0.38% 32
2023
Q2 		$420K Hold
11,774
– – 0.36% 36
2023
Q1 		$419K Sell
11,774
-1,000
-8% -$35K 0.37% 29
2022
Q4 		$449K Sell
12,774
-1,208
-9% -$40.2K 0.39% 32
2022
Q3 		$411K Hold
13,982
– – 0.37% 28
2022
Q2 		$761K Buy
13,982
+4,708
+51% +$260K 0.64% 17
2022
Q1 		$505K Hold
9,274
– – 0.36% 32
2021
Q4 		$511K Hold
9,274
– – 0.36% 35
2021
Q3 		$443K Buy
+9,274
New +$466K 0.35% 40

Other funds holding GSK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Innova Wealth Partners's GSK Position: Q2 2026 in Review

Innova Wealth Partners held its GSK (GSK) position steady in Q2 2026 at 6,940 shares worth $364K. The position accounts for 0.15% of the portfolio, ranked #120.

Innova Wealth Partners first reported a position in GSK in Q3 2021 and has held it in 19 quarters since. The position peaked at $761K in Q2 2022. 416 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Innova Wealth Partners held 6,940 shares of GSK worth $364K as of Q2 2026.
  • Innova Wealth Partners left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.15% of Innova Wealth Partners's portfolio in Q2 2026, its #120 holding.
  • Innova Wealth Partners first reported a position in GSK in Q3 2021 and has held it in 19 quarters since.
  • Innova Wealth Partners's GSK position peaked at $761K in Q2 2022.
  • 416 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Innova Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.